Inventor · disambiguated record
Longcheng Li
Also filed as: LI LONGCHENG
2 granted patents·14 pending applications·9 citations·filing 2006–2023
56Inventor score
Top patents by PatentIndex Score
16 records- 0180US9297008B2Small activating RNA molecules and methods of useUNIV CALIFORNIA·Filed 2014·Granted Mar 29, 2016·6 cites·7 claims
- 0268US8877721B2Small activating RNA molecules and methods of useLI LONGCHENG·Filed 2006·Granted Nov 4, 2014·3 cites·7 claims
- 0357US2025101421A1Oligonucleotide modulators activating utrophin expressionRACTIGEN THERAPEUTICS·Filed 2023·Application pending·0 cites
- 0452US2025297258A1Oligonucleotide-based delivery vehicle for oligonucleotides agents and methods of use thereofRACTIGEN THERAPEUTICS·Filed 2022·Application pending·0 cites
- 0550US2024327833A1Double-Stranded Nucleic Acid Molecule for Treating Proliferative Vitreoretinopathy and Use ThereofRACTIGEN THERAPEUTICS·Filed 2022·Application pending·0 cites
- 0650US2024301409A1Chemically Modified Small Activating RNARACTIGEN THERAPEUTICS·Filed 2022·Application pending·0 cites
- 0750US2024318174A1Multi-Valent Oligonucleotide Agent and Methods of Use ThereofRACTIGEN THERAPEUTICS·Filed 2022·Application pending·0 cites
- 0846US2022064642A1Oligomeric nucleic acid molecule and application thereofRACTIGEN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 0945US2023212565A1Nucleic acid molecule for treating thrombocytopenia and application thereofRACTIGEN THERAPEUTICS·Filed 2020·Application pending·0 cites
- 1043US2023220389A1Nucleic acid molecule targeting mitf gene and use thereofRACTIGEN THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1143US2023287416A1Combinatory treatment of sma with sarna and mrna modulatorsRACTIGEN THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1241US2022313721A1Oligomeric nucleic acid molecule activating atoh1 gene and use thereofRACTIGEN THERAPEUTICS·Filed 2020·Application pending·0 cites
- 1339US2022096350A1Oligonucleotides for skin careRACTIGEN THERAPEUTICS·Filed 2020·Application pending·0 cites
- 1438US2022096516A1Oligonucleotide molecule and application thereof in tumor therapyRACTIGEN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 1536US2021332366A1Novel Small Activating RNARACTIGEN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 1633US2021024915A1Method for activating p21 gene expressionRACTIGEN THERAPEUTICS·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →